CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Drugs.com Clinical Trial Results
Original article

Vistagen Announces Preliminary Positive Data from Open-Label Extension Portion of PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder

Phase 3
Related Companies

Read the original article

Published by Drugs.com Clinical Trial Results on September 22, 2026 11:09 PM

Read Original